Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
), to develop systems that improve the efficacy of machine learning-based technologies for healthcare applications. You must hold a PhD (or be near completion) in a field such as AI, computer science, signal
-
dynamics and (at intermediate redshifts) strong gravitational lensing, thus preserving and extending the team’s lead in this field. Applicants should have a PhD (or close to completion) in (Astro) physics
-
mechanisms by which co-inhibitory receptors, including PD-1, BTLA, TIGIT, and CD200R, regulate T cell function in autoimmune settings. Despite sharing common downstream signalling components such as SHP1 and
-
annum inclusive of Oxford University weighting Potential to under fill at grade 06RS: £34,982-£40,855 per annum inclusive of Oxford University weighting The Department of Computer Science seeks to employ
-
Ertegun Graduate Scholarship Programme in the Humanities The Mica and Ahmet Ertegun Graduate Scholarship Programme funds full-time graduate degrees in various subjects within the Humanities
-
have completed, or be close to completing, a PhD/DPhil in a relevant quantitative field such as computational social science, computer science, or cognitive science. They will have a demonstrable track
-
to scientific colleagues. Support the senior team in designing an internal funding programme for translational research projects to de-risk technology development. Manage the administrative activities related
-
. Selection criteria: • Hold, or be near to completion of, a PhD/DPhil in biomaterials, bioengineering, biology, chemistry, nanotechnology, or related field • Experience establishing and
-
will be required due to regulated activity involving children and ‘at risk’ adults. The successful candidate will hold, or have submitted a relevant PhD/DPhil (or equivalent) in a relevant discipline
-
offers a unique opportunity to lead a programme of research trials and clinical cancer activity for the Department of Oncology and Oxford Cancer. Our research focuses on the testing of novel therapies